Skip to content

Comparative Effectiveness of group therapy Beck cognitive interventions and motivational interviewing in overweight and obese women with type 2 diabetes

Comparative Effectiveness of group therapy Beck cognitive interventions and motivational interviewing on reduction of overweight, glycemic and lipids control and quality of life in overweight and obese women with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017022132698N1
Enrollment
40
Registered
2017-04-08
Start date
2017-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabete. Diabetes mellitus

Interventions

Intervention 1: The intervention groups in addition their usual medication or diet therapy gets 8 sessions of group therapy cognitive intervention. Intervention 2: The intervention groups in addition
Behavior
The intervention groups in addition their usual medication or diet therapy gets 8 sessions of group therapy cognitive intervention.
The intervention groups in addition their usual medication or diet therapy gets 8 sessions of group therapy motivational interviewing.

Sponsors

Vice Chancellor for research of Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having BMI=25; aged 18 to 65 years; female gender; diabetes; HbA1C=7; the minimum cycle level of education; the signing of moral consent to participate in research. Exclusion criteria: The risk of psychiatric disorders such as eating disorders; personality disorder; bipolar disorder; obsessive-compulsive disorder on interview and according to the criteria of DSM-V; under psychiatric treatment or psychotherapy; having a program of moderate exercise at least 20 minutes a day; three days a week regularly for weight loss in the past six months based on self-reported; weight loss diet under the supervision of specialists in the past six months based on self-reported, debilitating diseases, diabetic complications such as advanced retinopathy and nephropathy; mutilation; drugs affecting the metabolism or weight body examination by a general practitioner and individual reports

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1c (HbA1c). Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.;BMI. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.;Triglisirid. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.;Total Cholestrol. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.;HDL. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.;LDL. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: blood test.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: questionnaire.;Obesity-Related WELL-being. Timepoint: Before the intervention, After intervention, 4 months after intervention. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Farhoodi

Yazd Azad University

farzad_farhoodi@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026